Teva Pharmaceutical Industries News

Teva Pharmaceutical Indus Analyst Ratings

BenzingaMar 8 21:11

Piper Sandler Upgrades Teva Pharmaceutical Indus to Overweight, Raises Price Target to $19

BenzingaFeb 12 18:29

Teva Pharmaceutical Indus Analyst Ratings

BenzingaFeb 12 18:27

Barclays Maintains Overweight on Teva Pharmaceutical Indus, Raises Price Target to $17

BenzingaFeb 5 21:53

Teva Pharmaceutical Indus Analyst Ratings

BenzingaFeb 5 21:45

UBS Remains a Buy on Teva Pharmaceutical (TEVA)

TipRanksFeb 1 17:25

Teva Pharmaceutical Indus Analyst Ratings

BenzingaJan 29 20:03

Barclays Remains a Buy on Teva Pharmaceutical (TEVA)

TipRanksJan 29 18:07

Jefferies Upgrades Teva Pharmaceutical Indus to Buy, Raises Price Target to $14

BenzingaJan 23 18:54

Teva Pharmaceutical Indus Analyst Ratings

BenzingaJan 23 18:53

BofA Securities Adjusts Teva Pharmaceutical Industries Price Target to $14 From $13, Maintains Buy Rating

MT NewswiresJan 12 23:00

Piper Sandler Upgrades Teva Pharmaceutical Indus to Neutral, Raises Price Target to $12

BenzingaJan 3 17:44

Teva Pharmaceutical Indus Analyst Ratings

BenzingaJan 3 17:43

HSBC Initiates Coverage On Teva Pharmaceutical Indus With Buy Rating, Announces Price Target of $13

BenzingaDec 18, 2023 21:07

Teva Pharmaceutical Indus Analyst Ratings

BenzingaDec 18, 2023 21:05

UBS Upgrades Teva Pharmaceutical Indus to Buy, Raises Price Target to $13

BenzingaNov 27, 2023 18:43

Teva Pharmaceutical Indus Analyst Ratings

BenzingaNov 27, 2023 18:41

Alvotech Upgraded at Citi Citing FDA Nod for Biosimilars

Seeking AlphaOct 20, 2023 22:25

UBS Maintains Neutral on Teva Pharmaceutical Indus, Raises Price Target to $11

BenzingaSep 20, 2023 21:08

Teva Pharmaceutical Indus Analyst Ratings

BenzingaSep 20, 2023 21:07